MedPath

Phase 2 Clinical Study in Rheumatoid Arthritis With an Investigational Oral p38 MAP Kinase Inhibitor VX-702

Phase 2
Completed
Conditions
Rheumatoid Arthritis
Registration Number
NCT00205478
Lead Sponsor
Vertex Pharmaceuticals Incorporated
Brief Summary

The purpose of this study is to assess the clinical activity and safety of two doses of VX-702 compared to placebo in subjects with moderate to severe Rheumatoid Arthritis.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
300
Inclusion Criteria
  • Adults with active rheumatoid arthritis for greater than 6 months and evidence of inflammation.
Exclusion Criteria
  • Subjects who have conditions precluding the use of cytokine inhibitors or subjects who require DMARDs other than hydroxychloroquine or sulfasalazine are excluded.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
The primary endpoint for the study is the ACR20 response at Week 12.
Secondary Outcome Measures
NameTimeMethod
The ACR50 and ACR70 responses at 12 weeks will also be assessed as well as other measures.

Trial Locations

Locations (42)

Dniepropetrovsk State Medical Academy

๐Ÿ‡บ๐Ÿ‡ฆ

Dniepropetrovsk, Ukraine

Zaporizhya Medical Institute

๐Ÿ‡บ๐Ÿ‡ฆ

Zaporizhya, Ukraine

MBAL "Stara Zagora" EAD

๐Ÿ‡ง๐Ÿ‡ฌ

Stara Zagora, Bulgaria

Transport Hospital

๐Ÿ‡ง๐Ÿ‡ฌ

Sofia, Bulgaria

University Hospital Kralovske Vinohrady

๐Ÿ‡จ๐Ÿ‡ฟ

Praha 10, Czech Republic

Military Medical Academy - Sofia

๐Ÿ‡ง๐Ÿ‡ฌ

Sofia, Bulgaria

Wojewodzki Szpital Zespolony

๐Ÿ‡ต๐Ÿ‡ฑ

Elblag, Poland

Pirogov City Clinical Hospital #1

๐Ÿ‡ท๐Ÿ‡บ

Moscow, Russian Federation

Rheumatology Out-patient Department

๐Ÿ‡จ๐Ÿ‡ฟ

Praha 6, Czech Republic

Malopolskie Centrum Medyczne

๐Ÿ‡ต๐Ÿ‡ฑ

Krakow, Poland

Instytut Medycyny Wsi im. Witolda Chodzki

๐Ÿ‡ต๐Ÿ‡ฑ

Lublin, Poland

Szpital Specjalistyczny Nr 1

๐Ÿ‡ต๐Ÿ‡ฑ

Bytom, Poland

Institute of Gerontology of Ukrainian AMS

๐Ÿ‡บ๐Ÿ‡ฆ

Kiev, Ukraine

Medical University - Sofia

๐Ÿ‡ง๐Ÿ‡ฌ

Sofia, Bulgaria

Thalassotherapia

๐Ÿ‡ญ๐Ÿ‡ท

Opatija, Croatia

KBC Osijek Ambulanta za bol

๐Ÿ‡ญ๐Ÿ‡ท

Osijek, Croatia

Institute of Rheumatology - Niska Banja

Niska Banja, Former Serbia and Montenegro

University Hospital Centre Zagreb

๐Ÿ‡ญ๐Ÿ‡ท

Zagreb, Croatia

SZZ-Jizni Mesto II

๐Ÿ‡จ๐Ÿ‡ฟ

Praha 11, Czech Republic

Institute of Rheumatology

Beograd, Former Serbia and Montenegro

University Hospital U Sv.Anny

๐Ÿ‡จ๐Ÿ‡ฟ

Brno, Czech Republic

Clinical Center Zemun

Zemun, Former Serbia and Montenegro

"Gabinety Profesorow" Prywatna Praktyka

๐Ÿ‡ต๐Ÿ‡ฑ

Lublin, Poland

Wojewodzki Zespo๏ฟ…๏พ‚ Reumatologiczny im.

๐Ÿ‡ต๐Ÿ‡ฑ

Sopot, Poland

State Clinical Immunology Research

๐Ÿ‡ท๐Ÿ‡บ

Novosibirsk, Russian Federation

Ryazan Regional Clinical Cardiologic

๐Ÿ‡ท๐Ÿ‡บ

Ryazan, Russian Federation

Saint Petersburg Clinical Hospital

๐Ÿ‡ท๐Ÿ‡บ

Saint Petersburg, Russian Federation

Saint-Petersburg City Hospital

๐Ÿ‡ท๐Ÿ‡บ

Saint-Petersburg, Russian Federation

Saint-Petersburg Medical Academy

๐Ÿ‡ท๐Ÿ‡บ

Saint-Petersburg, Russian Federation

EVIDENCE Clinical and Pharmaceutical Research

๐Ÿ‡ท๐Ÿ‡บ

St. Petersburg, Russian Federation

National Institute of Rheumatic Diseases

๐Ÿ‡ธ๐Ÿ‡ฐ

Piestany, Slovakia

Clinical Center Ljubljana

๐Ÿ‡ธ๐Ÿ‡ฎ

Ljubljana, Slovenia

SanaClis s.r.o.

๐Ÿ‡บ๐Ÿ‡ฆ

Kiev, Ukraine

NZOZ "Nasz Lekarz" Praktyka Grupowa Lekarzy

๐Ÿ‡ต๐Ÿ‡ฑ

Torun, Poland

Okregowy Szpital Kolejowy

๐Ÿ‡ต๐Ÿ‡ฑ

Wroclaw, Poland

ZOZ Zyrardow

๐Ÿ‡ต๐Ÿ‡ฑ

Zyrardow, Poland

State Institute of Rheumatology of RAMS

๐Ÿ‡ท๐Ÿ‡บ

Moscow, Russian Federation

Saratov Regional Clinical Hospital

๐Ÿ‡ท๐Ÿ‡บ

Saratov, Russian Federation

Leningrad Regional Hospital

๐Ÿ‡ท๐Ÿ‡บ

St. Petersburg, Russian Federation

City Pokrovskaya Hospital

๐Ÿ‡ท๐Ÿ‡บ

St. Petersburg, Russian Federation

Donetsk State Medical University

๐Ÿ‡บ๐Ÿ‡ฆ

Donetsk, Ukraine

Institute of Cardiology of Ukranian AMS

๐Ÿ‡บ๐Ÿ‡ฆ

Kiev, Ukraine

ยฉ Copyright 2025. All Rights Reserved by MedPath